SEC filings · customer concentration · MRNA

Moderna's major customers

FFF Enterprises accounted for 15% of Moderna's revenue in FY 2025, about the same as 13% a year earlier. 1 listed supplier reports Moderna as a customer worth 10% or more of their revenue, led by Personalis at 22%.

3major customers now
39%of revenue from them
1listed suppliers depending on it
2016–2026years covered
Free

Get an email when Moderna's customer concentration changes

When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.

Major customers of Moderna

Customers that Moderna named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.

CustomerShare of revenueChange vs prior yearHistoryLatest filing
FFF Enterprises15%from 13%FY 2024: 13%FY 2025: 15%2 yearsFY 2025 · filed 20 Feb 2026
Public Works And Government Services Canada13%newFY 2025: 13%1 yearFY 2025 · filed 20 Feb 2026
Cardinal HealthCAH11%newFY 2025: 11%1 yearFY 2025 · filed 20 Feb 2026

Formerly disclosed

CustomerShare of revenueChange vs prior yearHistoryLatest filing
Strategic Collaborators80%last FY 2019FY 2016: 94%FY 2017: 86%FY 2018: 91%FY 2019: 80%4 yearsFY 2019 · filed 27 Feb 2020
Biomedical Advanced Research And Development Authority65%last FY 2020FY 2017: 10%FY 2019: 13%FY 2020: 65%3 yearsFY 2020 · filed 24 Feb 2023
Merck & Co.MRK61%last FY 2019FY 2016: 44%FY 2017: 31%FY 2018: 49%FY 2019: 61%4 yearsFY 2019 · filed 25 Feb 2022
Alexion36%last FY 2017FY 2016: 16%FY 2017: 36%2 yearsFY 2017 · filed 27 Feb 2020
AstraZenecaAZN34%last FY 2018FY 2016: 30%FY 2017: 15%FY 2018: 34%3 yearsFY 2018 · filed 26 Feb 2021
European Commission28%last FY 2022FY 2021: 32%FY 2022: 28%2 yearsFY 2022 · filed 21 Feb 2025
US Goverment23%last FY 2022FY 2020: 24%FY 2021: 29%FY 2022: 23%3 yearsFY 2022 · filed 21 Feb 2025
Ministry Of Health Labor And Welfare Of Japan21%last FY 2023FY 2023: 21%1 yearFY 2023 · filed 20 Feb 2026
UK Health Security Agency16%last FY 2024FY 2024: 16%1 yearFY 2024 · filed 20 Feb 2026
Takeda PharmaceuticalTAK10%last FY 2022FY 2022: 10%1 yearFY 2022 · filed 21 Feb 2025
VertexVERX10%last FY 2019FY 2019: 10%1 yearFY 2019 · filed 25 Feb 2022

Suppliers that depend on Moderna

Listed companies whose annual report names Moderna as a customer worth 10% or more of their revenue. If Moderna cuts orders or switches supplier, these are the companies that feel it.

SupplierIts revenue from this companyChange vs prior yearHistoryLatest filing
PersonalisPSNL22%▼ from 28%FY 2024: 28%FY 2025: 22%2 yearsFY 2025 · filed 26 Feb 2026

About this data

US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.

All companies · Latest dependency shifts · Bulk data and API